Sune Aggergaard

Sune Aggergaard is a Senior Director of Regulatory Affairs with extensive experience in regulatory strategy, project management, and clinical trials. Sune currently serves as the Director of Regulatory Affairs at Servier Symphogen, overseeing the regulatory strategy for antibody development projects in oncology and driving the preparation of critical submission documents. Previously, Sune held various roles within Novo Nordisk, including Associate Director of Clinical Development, where Sune managed multiple clinical trial activities and led a team in executing cardiovascular outcomes trials. Sune started their career as a Clinical Research Associate and also contributed to academia as a teacher of Human Physiology and Basic Chemistry.